What Is Sermorelin?
Sermorelin is the most direct way to tell your pituitary gland to make more growth hormone — without bypassing the system entirely. It's a synthetic 29-amino acid peptide that mirrors the first 29 residues of endogenous growth hormone releasing hormone (GHRH), which is enough to fully activate the GHRH receptor and trigger GH secretion from the pituitary.[1]
That distinction matters. Direct human growth hormone (HGH) injections flood your system with exogenous GH, bypassing your body's feedback loops. Sermorelin works upstream — it asks your pituitary to do the work, which means the GH release remains pulsatile, regulated, and responsive to normal physiological signals like sleep, exercise, and blood glucose. You get GH production that looks more like what a healthy 30-year-old produces rather than a flat pharmacological dose.
Sermorelin has a longer history than most peptides discussed in anti-aging clinics. It was previously marketed as Geref (Serono) and held FDA approval for the treatment of idiopathic growth hormone deficiency in children. That brand was voluntarily discontinued in 2008 — not due to safety concerns, but for commercial reasons. Today it remains legally available through licensed compounding pharmacies by prescription, making it one of the more accessible options in the growth hormone secretagogue category.